| 经皮冠状动脉介入治疗术后支架内再狭窄的研究进展 |
| |
| 引用本文： | 阎之仪,汤圣兴. 经皮冠状动脉介入治疗术后支架内再狭窄的研究进展[J]. 安徽医药, 2016, 20(2): 227-231 |
| |
| 作者姓名： | 阎之仪 汤圣兴 |
| |
| 作者单位： | 皖南医学院弋矶山医院心内科,安徽 芜湖,241001;皖南医学院弋矶山医院心内科,安徽 芜湖,241001 |
| |
| 摘 要： | 支架内再狭窄是冠心病介入治疗中面临的重大医学难题,也是研究的热点,其主要发生机制是平滑肌过度增生,血管壁的重塑,炎性反应等。防治支架内再狭窄的方法有生活方式的改变,抗血小板药物的应用,支架的再植入,新型支架材料的应用等。现就支架内再狭窄的研究进展予以综述。
|
| 关 键 词： | 支架内再狭窄 药物洗脱支架 发生机制 防治方法 研究进展 |
| 收稿时间： | 2015-09-29 |
| 修稿时间： | 2015-11-10 |
Research progress of in-stent restenosis after percutaneous coronary intervention (PCI) |
| |
| Affiliation: | PCI and PCI |
| |
| Abstract: | In-stent restenosis is an important medical problem in interventional therapy,and also a research hotspot.Its main mechanism includes hyperplasia of smooth muscle,remodeling of the vascular wall and inflammatory reaction and so on.There are several methods to prevent in-stent restenosis depending on proper exercise,quit smoking,limiting use of alcohol and antiplatelet drugs,drug-eluting stents reimplantation and new material stents application etc..The research progress of in-stent restenosis after PCI was summarize in the paper. |
| |
| Keywords: | in-stent restenosis drug-eluting stent mechanism prevention and treatment research progress |
| 本文献已被 万方数据 等数据库收录！ |
| 点击此处可从《安徽医药》浏览原始摘要信息 |
|
点击此处可从《安徽医药》下载全文 |
|
